EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

Mohammed H Elkomy iD, Fatma I Abo El-Ela, Randa Mohammed Zaki, Omar A Alsaidan iD, Mohammed Elmowafy iD, Ameeduzzafar Zafar iD, Khaled Shalaby, Mohamed A Abdelgawad iD, Hany A Omar iD, Rania Salama, Hussein M Eid iD

Pharmaceutics · 07.08.2023 · 15 (8) · 2095

DOI: 10.3390/pharmaceutics15082095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.08.2023. Verfasst von Mohammed H Elkomy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSR NIH HHS, Al Jouf University, Deanship of Scientific Research at Jouf University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a serious mental disorder and the most prevalent cause of disability and suicide worldwide. Quercetin (QER) demonstrated antidepressant effects in rats exhibiting anxiety and depressive-like behaviors. In an attempt to improve QER’s antidepressant activity, a QER-loaded transferosome (QER-TFS) thermosensitive gel for intranasal administration was formulated and optimized. The therapeutic effectiveness of the optimized formulation was assessed in a depressed rat model by conducting a behavioral analysis. Behavioral study criteria such as immobility, swimming, climbing, sucrose intake, number of crossed lines, rearing, active interaction, and latency to feed were all considerably enhanced by intranasal treatment with the QER-TFS in situ gel in contrast to other formulations. A nasal histopathological study indicated that the QER-TFS thermosensitive gel was safe for the nasal mucosa. An immunohistochemical analysis showed that the animals treated with the QER-TFS thermosensitive gel had the lowest levels of c-fos protein expression, and brain histopathological changes in the depressed rats were alleviated. According to pharmacodynamic, immunohistochemical, and histopathological experiments, the intranasal administration of the QER-TFS thermosensitive gel substantially alleviated depressive symptoms in rats. However, extensive preclinical investigations in higher animal models are needed to anticipate its effectiveness in humans.

Schlagwörter

Stichwörter der Autor:innen

depressionforced swim testintranasalpharmacodynamicsquercetintransferosomes

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia.
  • College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.

ORCID-Profile: Mohammed H Elkomy, Omar A Alsaidan, Mohammed Elmowafy, Ameeduzzafar Zafar, Mohamed A Abdelgawad, Hany A Omar, Hussein M Eid

Förderung

  • CSR NIH HHS
  • Al Jouf University
  • Deanship of Scientific Research at Jouf University

Zitieren

APA

Elkomy, M. H., Abo El-Ela, F. I., Zaki, R. M., Alsaidan, O. A., Elmowafy, M., Zafar, A., Shalaby, K., Abdelgawad, M. A., Omar, H. A., Salama, R., & Eid, H. M. (2023). Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model. Pharmaceutics, 15(8), 2095. https://doi.org/10.3390/pharmaceutics15082095

Vancouver

Elkomy MH, Abo El-Ela FI, Zaki RM, Alsaidan OA, Elmowafy M, Zafar A, et al. Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model. Pharmaceutics. 2023;15(8):2095. doi:10.3390/pharmaceutics15082095

BibTeX
@article{Elkomy2023,
  author = {Elkomy, Mohammed H and Abo El-Ela, Fatma I and Zaki, Randa Mohammed and Alsaidan, Omar A and Elmowafy, Mohammed and Zafar, Ameeduzzafar and Shalaby, Khaled and Abdelgawad, Mohamed A and Omar, Hany A and Salama, Rania and Eid, Hussein M},
  title = {Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {2095},
  doi = {10.3390/pharmaceutics15082095}
}
Kostenlos starten →